Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Margaret Hamburg: The Public Health Commissioner

This article was originally published in RPM Report

Executive Summary

An interview with newly confirmed FDA Commissioner Margaret Hamburg.

You may also be interested in...



Drug Pricing Activity At US FDA May Be Unique To Gottlieb Tenure

Steven Grossman argues that the former commissioner possessed the credentials to be out front on the pricing issue, unlike other recent FDA commissioners and the current holder of the office.

Personalized Medicine Versus The Public Health: FDA Debates The “Polypill”

FDA is beginning to solicit input from the medical community on review issues for a multi-ingredient cardiovascular product designed to control hypertension, platelet aggregation and cholesterol levels. The key issue is whether convenience and broad access make up for loss of individualized dosing. That is an important debate in the era of personalized medicine.

ReGen Redux: Does a Troubled Medical Device Review Hold Any Lesson For Drugs?

The tainted FDA review and approval of a small medical device-a meniscal repair scaffolding--may have some important implications for drug reviews in the future and the checks-and-balances structure of the agency.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS080581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel